President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to head the Department of Health and Human Services has sent shockwaves through vaccine company stocks.
BioNTech and Novavax saw their stocks drop by 7.1% and 7.0%, respectively, while Moderna’s fell by 5.6% shortly after Trump’s announcement on Thursday, according to Axios. CNBC noted that Pfizer’s stocks dropped more than 2 percent.
These companies made billions after manufacturing the COVID-19 vaccines, which several governments, including the U.S., forced Americans to take.
It's GLORIOUS pic.twitter.com/Y0sKI746YK
— Jordan Schachtel @ dossier.today (@JordanSchachtel) November 14, 2024
Trump’s appointment of RFK Jr. to HHS seems part of the former independent presidential candidate’s efforts to “Make America Healthy Again,” echoing Trump’s signature “Make America Great Again” slogan.
“Mr. Kennedy will restore these Agencies to the traditions of Gold Standard Scientific Research, and beacons of Transparency, to end the Chronic Disease epidemic, and to Make America Great and Healthy Again!” Trump wrote on Truth Social. […]
— Read More: headlineusa.com
